We Can Medicines Co (ROCO:6929) Change In Working Capital : NT$-140 Mil (TTM As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is We Can Medicines Co Change In Working Capital?

We Can Medicines Co's change in working capital for the quarter that ended in Sep. 2024 was NT$-4 Mil.

We Can Medicines Co's change in working capital for the fiscal year that ended in Dec. 2023 was NT$-182 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).

We Can Medicines Co Change In Working Capital Historical Data

The historical data trend for We Can Medicines Co's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

We Can Medicines Co Change In Working Capital Chart

We Can Medicines Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Change In Working Capital

-174.89

188.47

-65.68

-181.66

We Can Medicines Co Quarterly Data
	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Change In Working Capital	Get a 7-Day Free Trial								-52.39	-28.17	-56.45	-51.73	-3.69

We Can Medicines Co Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-140 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows	Fiscal Years Ended	January 31,	(Amounts in millions)
Cash flows from operating activities:	2014	2013	2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net	(566)	(614)	(796)
Inventories	(1,667)	(2,759)	(3,727)
Accounts payable	531	1,061	2,687
Accrued liabilities	103	271	(935)
Accrued income taxes	(1,224)	981	994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

We Can Medicines Co Change In Working Capital Related Terms

Thank you for viewing the detailed overview of We Can Medicines Co's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

We Can Medicines Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » We Can Medicines Co Ltd (ROCO:6929) » Definitions » Change In Working Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

Section 4, Taiwan Avenue, 20th Floor-1, No. 925, Xitun District, Taichung, TWN

Website

http://www.yourchance.com.tw

We Can Medicines Co Ltd is a Taiwan-based company mainly engaged in the operation of chain cosmeceutical drugstores. The Company's main products include pharmaceuticals and health food, maternity and infant products, medical supplies, beauty cosmetics, and daily necessities.

We Can Medicines Co Headlines

No Headlines